resveratrol has been researched along with Small Cell Lung Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, F; Li, C; Li, W; Ma, L | 1 |
| Jin, F; Li, W; Ma, L; Pan, L; Shi, Y; Wang, R | 1 |
2 other study(ies) available for resveratrol and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway.
Topics: Antioxidants; Apoptosis; Apoptosis Inducing Factor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Resveratrol; Signal Transduction; Small Cell Lung Carcinoma | 2020 |
Resveratrol promotes the sensitivity of small-cell lung cancer H446 cells to cisplatin by regulating intrinsic apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; bcl-X Protein; Cell Line, Tumor; Cisplatin; Cytochromes c; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Small Cell Lung Carcinoma | 2018 |